UNITY Biotechnology Inc UBX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 11/25/22 EST
2.55quote price arrow down-0.04 (-1.54%)
Volume
125
Close
2.59quote price arrow up+0.19 (+7.92%)
Volume
214,131
52 week range
2.09 - 23.60
Loading...
  • Open2.45
  • Day High2.60
  • Day Low2.42
  • Prev Close2.40
  • 52 Week High23.60
  • 52 Week High Date11/26/21
  • 52 Week Low2.09
  • 52 Week Low Date11/10/22

Key Stats

  • Market Cap36.758M
  • Shares Out14.19M
  • 10 Day Average Volume0.33M
  • Dividend-
  • Dividend Yield-
  • Beta0.61
  • YTD % Change-82.26

KEY STATS

  • Open2.45
  • Day High2.60
  • Day Low2.42
  • Prev Close2.40
  • 52 Week High23.60
  • 52 Week High Date11/26/21
  • 52 Week Low2.09
  • 52 Week Low Date11/10/22
  • Market Cap36.758M
  • Shares Out14.19M
  • 10 Day Average Volume0.33M
  • Dividend-
  • Dividend Yield-
  • Beta0.61
  • YTD % Change-82.26

RATIOS/PROFITABILITY

  • EPS (TTM)-20.13
  • P/E (TTM)-0.13
  • Fwd P/E (NTM)-0.50
  • EBITDA (TTM)-51.111M
  • ROE (TTM)-82.84%
  • Revenue (TTM)5.02M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,124.56%
  • Debt To Equity (MRQ)25.50%

EVENTS

  • Earnings Date03/13/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On UNITY Biotechnology Inc

 

Profile

MORE
Unity Biotechnology, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing a portfolio of programs targeting specific biological mechanisms implicated in diseases of aging. The Company is focused on creating senolytic medicines to selectively eliminate senescent cells and thereby treat diseases of aging, such as ophthalmologic diseases, with the opportunity to explore neurology and other therapeutic areas. The Company's product includes UBX1325...
Keith Leonard Jr.
Chairman of the Board
Anirvan Ghosh Ph.D.
Chief Executive Officer, Director
Lynne Sullivan CPA
Chief Financial Officer, Head of Corporate Development
Alexander Nguyen J.D.
General Counsel and Corporate Secretary
Jason Damiano Ph.D.
Vice President of Translational Biology
Address
285 EAST GRAND AVENUE
South San Francisco, CA
94080
United States